Cracking the Code of Rare Brain Diseases -A Clinical Insight on Progressive Multifocal Leukoencephlopathy

Rare diseases of the central nervous system (CNS) represent an enormous, yet frequently overlooked, health burden; this is particularly true in countries like India, where the agenda is predominantly dominated by infectious and lifestyle diseases. This largely stems from the fact that rare diseases are usually of genetic origin or neurodegenerative in nature where patients encounter diagnostic delays and treatment options are limited because of accessibility to specialized care. Progressive Multifocal Leukoencephalopathy (PML) is a rare demyelinating disorder which has been diagnosed more often in recent times and continues to be a health burden for many. *¹ Progressive Multifocal Leukoencephalopathy (PML) represents a rare yet increasingly diagnosed condition which results from the JC virus reactivation in people with weakened immune systems. The immune system suppression caused by natalizumab and rituximab and fingolimod has led to the emergence of PML cases among patients despite its previous history of occurrence mainly in AIDS patients. In PML, JC virus reactivation leads to infection of oligodendrocytes, culminating in widespread demyelination which produces symptoms that include motor and visual impairments along with cognitive deterioration and ataxia. *² Medical professionals diagnose the condition by analyzing MRI results along with JC virus DNA presence in cerebrospinal fluid. The main obstacle to early detection exists because PML symptoms resemble other CNS diseases. Currently, immune reconstitution remains the cornerstone of PML management by antiretroviral therapy for HIV patients and immunosuppressant withdrawal for others. This article establishes the urgent necessity to raise awareness about rare CNS diseases while promoting genetic testing alongside patient learning and healthcare policies that support these conditions. The research demonstrates how studying uncommon medical disorders contributes to expanding knowledge about neurological and immunological systems.